Tracking influenza's every movementMay 20, 2008Former Santa Fe Institute researcher traces migration patterns of flu virus It's the case of the missing flu virus. When the flu isn't making people sick, it seems to just vanish. Yet, every year, everywhere on Earth, it reappears in the appropriate season and starts its attack. So where does it go when it disappears? Does it hibernate, lying dormant in a few people and preparing for its next onslaught? Does it bounce around from the Northern hemisphere to the Southern hemisphere and back, following the seasons? Neither, it turns out. The virus's breeding grounds are in Asia, a crew of virus-hunters has found, and it then teems out to take over the world anew each year. New varieties almost always evolve in Asia and then hitch a ride with travelers, spreading to Europe, Australia and North America and finally to South America, where they die away.
The work may make the flu vaccine even better than it already is. Because the flu virus is constantly evolving, scientists meet at the World Health Organization twice a year to decide whether to update the vaccine. Their job is made harder because they have to decide on a formulation a year in advance of when the flu will actually hit, to allow time for the vaccine to be manufactured and administered. So they have to predict which of the strains of flu virus are going to be causing the most disease a year down the line. "In order to try to predict how flu viruses might evolve, we have to understand how they're moving around the world and where they're evolving," says Derek Smith, now of the University of Cambridge and formerly of the Santa Fe Institute, corresponding author of the research. Asia, the study suggests, is the best place to look for up-and-coming strains. The team published its findings April 18 in Science (http://www.sciencemag.org/cgi/content/full/320/5874/340). The team traced the virus's steps by studying 13,000 flu samples from around the world. The World Health Organization Global Influenza Surveillance Network collected this data between 2002 and 2007, keeping track of when and where different strains of the virus popped up. They analyzed the shape differences between the proteins each virus uses to bind to human cells, along with the genetic makeup of each virus. The team used this information to create an "antigenic map" which visually shows the relationships between all the different viruses. This map allowed them to determine the migration patterns of the virus around the world. The work was funded by an NIH Director's Pioneer Award (http://nihroadmap.nih.gov/pioneer) to Smith given for highly innovative research that has the potential for big impacts. The roots of the project extend all the way back to when Smith was a graduate fellow at the Santa Fe Institute doing a PhD with Stephanie Forrest and Alan Perelson. He later began collaborating with Alan Lapedes, Robert Farber, and Terry Jones, all of whom were also affiliated with the Santa Fe Institute, to develop the methods and software to build antigenic maps. "This work is highly multidisciplinary, with epidemiologists, computer scientists, computational biologists, mathematicians, virologists, immunologists, geneticists, veterinarians, and MDs," Smith says. "It was made possible by collaborations with people from all of these disciplines. The Santa Fe Institute is one of the few places that could have gestated such work and I am immensely grateful for the 5 years I spent at SFI." Santa Fe Institute | |||||||||||||||||||||
|
Related Flu Virus News Articles Discovery opens door for drugs to fight bird flu, other influenza epidemics Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza. Survivors of 1918 flu pandemic protected with a lifetime immunity to virus New research has discovered that infection and natural exposure to the 1918 influenza virus made survivors immune to the disease for the remaining of their lives. Yale study shows why cigarette smoke makes flu, other viral infections worse A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage. Scientists create first successful libraries of avian flu virus antibodies An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey. 1 in 7 cases of bird flu could be prevented by closing schools in event of pandemic Closing schools in the event of a flu pandemic could slow the spread of the virus and prevent up to one in seven cases, according to a new study published today in the journal Nature. UT Knoxville research may lead to better flu vaccine New research from a scientist at the University of Tennessee, Knoxville, has uncovered information that may someday lead to a better flu vaccine. MIT explains spread of 1918 flu MIT researchers have explained why two mutations in the H1N1 avian flu virus were critical for viral transmission in humans during the 1918 pandemic outbreak that killed at least 50 million people. Iowa State chemists track how drug changes, blocks flu virus An anti-virus drug attacks influenza A by changing the motion and structure of a proton channel necessary for the virus to infect healthy cells, according to a recently published research paper by two Iowa State University chemists. Cell death suppression increases efficacy of M2 vaccines Significant public attention has recently been focused on the development of new anti-influenza (flu) vaccines that provide protection against a broad spectrum of viral strains. One proposed strategy is to utilize conserved viral protein, M2. Clinical trials of M2-containing influenza vaccines were recently initiated by US and European companies. MIT finds key to avian flu in humans MIT researchers have uncovered a critical difference between flu viruses that infect birds and humans, a discovery that could help scientists monitor the evolution of avian flu strains and aid in the development of vaccines against a deadly flu pandemic. More Flu Virus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||